{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifpxpqqahg5lqmubnnexdr2hzb4lamm5upziudbkyi7th5pefxzdq",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mf3l7twte4d2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifh4zj7xek7fhstrkr6fz3wo5oawlfjdw235ungob2m3fzxilt5b4"
    },
    "mimeType": "image/jpeg",
    "size": 481458
  },
  "path": "/news/2026-02-nanoparticle-based-gene-treatment-options.html",
  "publishedAt": "2026-02-17T17:00:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Diseases, Conditions, Syndromes"
  ],
  "textContent": "UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells, restoring key biological function in a laboratory model of cystic fibrosis and establishing a potential new path toward mutation-agnostic gene therapy for inherited lung diseases.",
  "title": "Nanoparticle-based gene editing could expand treatment options for cystic fibrosis"
}